CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
TOTAL REVENUE		$ 14,183	$ 12,054	$ 39,021	$ 29,801
COST OF GOODS SOLD	[1]	(7,074)	(3,703)	(17,195)	(13,201)
RESEARCH AND DEVELOPMENT EXPENSES	[2]	(7,386)	(7,282)	(23,732)	(22,093)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	[3]	(2,848)	(2,954)	(8,613)	(9,263)
OPERATING LOSS		(3,125)	(1,885)	(10,519)	(14,756)
FINANCIAL EXPENSES		(639)	(2,410)	(1,879)	(6,613)
FINANCIAL INCOME		197	96	1,211	403
FINANCIAL EXPENSES, NET		(442)	(2,314)	(668)	(6,210)
OTHER INCOME					51
NET LOSS FOR THE PERIOD		$ (3,567)	$ (4,199)	$ (11,187)	$ (20,915)
LOSS PER SHARE OF COMMON STOCK - BASIC		$ (0.07)	$ (0.09)	$ (0.24)	$ (0.48)
LOSS PER SHARE OF COMMON STOCK - DILUTED		$ (0.07)	$ (0.09)	$ (0.24)	$ (0.48)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC		49,498,105	45,556,647	47,582,733	43,761,769
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED		49,498,105	45,556,647	47,582,733	43,761,769
Goods
TOTAL REVENUE		$ 8,812	$ 4,506	$ 21,222	$ 12,260
License and R&D Services
TOTAL REVENUE		$ 5,371	$ 7,548	$ 17,799	$ 17,541

[1] (1) Includes share-based compensation

[2] (2) Includes share-based compensation

[3] (3) Includes share-based compensation